// App-Quantinova.ai

BSH2020‐EP‐005 : The clinical significance of FLT3‐ITD allele burden in AML – a long‐term retrospective single centre study

Researchers

Presenter

  • A. Duguid

Principal Investigators

  • S. Talas

  • L. Gilroy

  • V. Campbell

Medical Centers

  • Department of Haematology, Western General Hospital

  • University of Edinburgh,

  • Haematology Malignancy Diagnostic Services, Western General Hospital, Edinburgh, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Nuclear pore complex protein Nup214

  • Nucleophosmin 1

  • Promyelocytic Leukemia

  • DEK Proto-Oncogene

  • Fms related tyrosine kinase 3

  • White Blood Cell

Drug/Treatment

  • L-Tyrosine

  • Tretinoin

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved